Predicting prognosis of locally advanced esophageal squamous cell carcinoma through early changes in neutrophil-to-lymphocyte ratio following neoadjuvant immunochemotherapy
Patients with a decrease in NLR value of more than 35% after the first cycle of immunochemotherapy may be associated with a worse clinical outcome in ESCC. NLR-Δ shows potential as an early-detection biomarker for NAIC-treated ESCC.
Authors
- Guibin Qiao (ORCID: https://orcid.org/0000-0001-9200-9317)
- Zihua Lan (ORCID: https://orcid.org/0000-0002-7292-5454)
- Zhen Gao (ORCID: https://orcid.org/0000-0001-7013-5312)
- Yizhang Chen (ORCID: https://orcid.org/0000-0003-3873-4352)
- Yong Tang (ORCID: https://orcid.org/0000-0001-9478-5205)
- Shujie Huang (ORCID: https://orcid.org/0000-0002-2339-0684)
- Zijie Li (ORCID: https://orcid.org/0000-0002-1860-1029)
- Rixin Chen (ORCID: https://orcid.org/0000-0002-6729-4299)
- Sichao Wang (ORCID: https://orcid.org/0000-0002-2286-178X)
Institutions
- Shantou University (CN)
- ShenZhen People’s Hospital (CN)
- Shantou University Medical College (CN)
- Zhujiang Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2024-12-01
- DOI
- https://doi.org/10.21037/jtd-24-1115
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Guangdong Provincial People's Hospital
- Guangzhou Municipal Science and Technology Project